))
Revolutionizing Alzheimer's Research: AI-Driven Solutions for Brain Health
Manage episode 433144936 series 3562000
Conteúdo fornecido por CRC Broadcasting, Co. and Bob Roth. Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por CRC Broadcasting, Co. and Bob Roth ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
Dr. Rui Chang, founder of Path Biotech and professor at the University of Arizona, is leveraging artificial intelligence to revolutionize Alzheimer's and dementia research. With over 16 years of experience in AI, Dr. Chang's work includes analyzing entire genomes simultaneously, predicting drug targets, and launching AI-predicted clinical trials for Alzheimer's treatment. His research extends to Lewy Body Dementia and glioblastoma, collaborating with institutions like Mayo Clinic. Dr. Chang has also developed a nutraceutical product, Cognition Protect, for those concerned about cognitive decline. His work represents a significant advancement in precision medicine and offers hope for more effective treatments in neurology. The interview highlights the potential of AI in accelerating medical research and improving patient outcomes. #AlzheimersResearch #ArtificialIntelligence #BrainHealth #Neuroscience #PrecisionMedicine #AIinHealthcare #DementiaResearch #CognitiveHealth
…
continue reading
66 episódios
Compartilhar
